title: Bone marrow transplantation for childhood Ki-1 lymphoma.
abstract: Two children with Ki-1 antigen-positive, non-Hodgkin's lymphoma received high-dose chemotherapy, fractionated total body irradiation (TBI), and allogeneic bone marrow transplantation. Both patients had relapsed multiple times on conventional chemotherapy and radiation therapy. Following transplantation, there was successful engraftment with disappearance of clinical signs and symptoms of their disease. As of June 1, 1989 they are in continuous unmaintained complete remission, 56 and 40 months, respectively, after bone marrow transplantation.
authors.affiliation: Division of Allergy, Children's Hospital of Philadelphia, PA 19104.
authors.forename: V
authors.initials: V
authors.lastname: Chakravarti
authors.forename: N R
authors.initials: NR
authors.lastname: Kamani
authors.forename: E
authors.initials: E
authors.lastname: Bayever
authors.forename: B
authors.initials: B
authors.lastname: Lange
authors.forename: P
authors.initials: P
authors.lastname: Herzog
authors.forename: J E
authors.initials: JE
authors.lastname: Sanders
authors.forename: C S
authors.initials: CS
authors.lastname: August
mesh_terms: D000293:Adolescent; D000943:Antigens, Differentiation / Q000032:analysis; D000951:Antigens, Neoplasm / Q000032:analysis; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D016026:Bone Marrow Transplantation; D002648:Child; D003131:Combined Modality Therapy; D006801:Humans; D017730:Ki-1 Antigen; D008228:Lymphoma, Non-Hodgkin / Q000276:immunology / Q000601:surgery*; D008297:Male; D012074:Remission Induction
chemical_list: D000943:Antigens, Differentiation; D000951:Antigens, Neoplasm; D017730:Ki-1 Antigen